Literature DB >> 3519731

Effects of early reperfusion in acute myocardial infarction on arrhythmias induced by programmed stimulation: a prospective, randomized study.

I E Kersschot, P Brugada, M Ramentol, M Zehender, B Waldecker, W G Stevenson, A Geibel, C De Zwaan, H J Wellens.   

Abstract

This study compares inducibility of ventricular tachyarrhythmias by programmed electrical stimulation of the heart in patients with myocardial infarction with and without reperfusion after streptokinase therapy. Sixty-two consecutive patients admitted with an acute myocardial infarction were randomized to either combined intravenous and intracoronary streptokinase (streptokinase group) or to standard coronary care unit treatment (control group). Thirty-six of the 62 patients (21 patients from the streptokinase and 15 from the control group) with a first myocardial infarction were studied by programmed ventricular stimulation after a mean of 26 +/- 14 days. No patient had a history of antiarrhythmic drug use or documentation of a ventricular arrhythmia before the initial admission. A sustained ventricular arrhythmia was induced in 10 (48%) of the 21 patients randomized to streptokinase therapy and in all 15 (100%) control patients (p less than 0.001). Sustained monomorphic ventricular tachycardia was induced in 6 (29%) and 10 (67%) patients, respectively (p less than 0.05). To terminate an induced arrhythmia, direct current countershock was required in 33% of patients in the streptokinase group and 73% of patients in the control group (p less than 0.02). Seventeen of the 21 patients treated with streptokinase and no control patient had evidence of early reperfusion 200 +/- 70 minutes after the onset of pain. In comparison with patients without early reperfusion, patients in the reperfused group had a lower maximal serum creatine kinase value (p less than 0.01), a shorter time to peak creatine kinase value (p less than 0.001) and a higher angiographic left ventricular ejection fraction (62 versus 45%, p less than 0.01).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3519731     DOI: 10.1016/s0735-1097(86)80141-3

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  11 in total

1.  Current status of thrombolytic therapy in acute myocardial infarction.

Authors:  B Stein; R Roberts
Journal:  Tex Heart Inst J       Date:  1991

Review 2.  Late potentials as predictors of risk after thrombolytic treatment?

Authors:  G Breithardt; M Borggrefe; U Karbenn
Journal:  Br Heart J       Date:  1990-09

3.  The Open Artery: Electrophysiologic Considerations.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1997       Impact factor: 2.300

4.  The Open-Artery Hypothesis: An Overview.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1997       Impact factor: 2.300

5.  The effects of oral pretreatment with zofenopril, an angiotensin-converting enzyme inhibitor, on early reperfusion and subsequent electrophysiologic stability in the pig.

Authors:  R A Tio; C D de Langen; P A de Graeff; W H van Gilst; K J Bel; K G Wolters; P H Mook; J van Wijngaarden; H Wesseling
Journal:  Cardiovasc Drugs Ther       Date:  1990-06       Impact factor: 3.727

6.  Intravenous streptokinase for acute myocardial infarction reduces the occurrence of ventricular late potentials.

Authors:  E W Chew; P Morton; J G Murtagh; M E Scott; D B O'Keeffe
Journal:  Br Heart J       Date:  1990-07

7.  Effect of thrombolysis on the evolution of late potentials within 10 days of infarction.

Authors:  M Eldar; J Leor; H Hod; Z Rotstein; S Truman; E Kaplinsky; S Abboud
Journal:  Br Heart J       Date:  1990-05

8.  Significance of perfusion of the infarct related coronary artery for susceptibility to ventricular tachyarrhythmias in patients with previous myocardial infarction.

Authors:  H V Huikuri; M J Koistinen; K E Airaksinen; M J Ikäheimo
Journal:  Heart       Date:  1996-01       Impact factor: 5.994

9.  Magnetic resonance-based anatomical analysis of scar-related ventricular tachycardia: implications for catheter ablation.

Authors:  Hiroshi Ashikaga; Tetsuo Sasano; Jun Dong; M Muz Zviman; Robert Evers; Bruce Hopenfeld; Valeria Castro; Robert H Helm; Timm Dickfeld; Saman Nazarian; J Kevin Donahue; Ronald D Berger; Hugh Calkins; M Roselle Abraham; Eduardo Marbán; Albert C Lardo; Elliot R McVeigh; Henry R Halperin
Journal:  Circ Res       Date:  2007-10-04       Impact factor: 17.367

Review 10.  Risk stratification after myocardial infarction: role of electrical instability, ischemia, and left ventricular function.

Authors:  A Bayés-de-Luna; X Viñolas; J Guindo; A Bayés-Genis
Journal:  Cardiovasc Drugs Ther       Date:  1994-05       Impact factor: 3.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.